This profile is built from public research funding records (CIHR, NSERC and SSHRC). We have not imported them from a University of Calgary directory, so their publications, courses and email address may be missing. Find their university profile.
Latest funding
- $400,000
The PARTUM (Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity) Trial
CIHR · 2024 · Principal investigator
The PARTUM (Postpartum Aspirin to Reduce Thromboembolism Undue Morbidity) Trial
Principal investigators: Skeith, Leslie; Baumann Kreuziger, Lisa; CHAULEUR, celine; de Boer, Marjon A; Donnelly, Jennifer; El-Chaar, Darine; Eslick, Renee; Guerrero, Maria C; Malinowski, Ann K; Roberts, Lara; Rodger, Marc A
Keywords: Aspirin; Low-Molecular-Weight Heparin; Postpartum; Prevention; Venous Thromboembolism
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.